SCHEMBL3660167

SCHEMBL3660167

c1ccc(CO[C]2CCC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
PTGS1 P23219 1/20 0.47
SLC6A2 P23975 1/20 0.47
CYP2C19 P33261 1/20 0.47
PTGS2 P35354 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HIF1A Q16665 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
MAOB P27338 5/20 0.46
MAOA P21397 3/20 0.46
MAPT P10636 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
IDO1 P14902 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3278335 0.95 TSHR (0.48) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL1061320 0.93 TSHR (0.46) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL6469379 0.91 TSHR (0.52) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL17597872 0.80 FFAR1 (0.51) TDP1HPDBCHE
SCHEMBL29285290 0.74 LMNA (0.48) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL12472442 0.71 HRH3 (0.72) LMNAMAOBMAOAMAPTL3MBTL1
SCHEMBL6649336 0.71 TSHR (0.65) TSHRLMNAIDO1LTA4HAGXT
SCHEMBL6327555 0.71 CYP3A4 (0.47) TSHRLMNACYP1A2PTGS1SLC6A2
Cyclohexane SCHEMBL8149682 0.70 TSHR (0.83) TSHRLMNAIDO1LTA4HAGXT
SCHEMBL339813 0.70 LMNA (0.82) LMNACYP1A2PTGS1SLC6A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139854-A2 P1-NONEPIMERIZABLE KETOAMIDE INHIBITORS OF HCV NS3 PROTEASE SCHERING CORPORATION (US) 2010-01-06 EP claimed
WO-2009008913-A2 P1-NONEPIMERIZABLE KETOAMIDE INHIBITORS OF HCV NS3 PROTEASE SCHERING CORPORATION (US) 2009-01-15 WO claimed
EP-4384493-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2024-06-19 EP disclosed
EP-4168398-A1 TYK-2 INHIBITOR BeiGene, Ltd. (KY) 2023-04-26 EP disclosed
WO-2023016447-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-02-16 WO disclosed
WO-2022127756-A1 COMPOUNDS AS CASEIN KINASE INHIBITORS Gritscience Biopharmaceuticals Co., Ltd. (CN) 2022-06-23 WO disclosed
WO-2022012622-A1 DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2022-01-20 WO disclosed
WO-2021259208-A1 TYK-2 INHIBITOR BEIGENE, LTD. (KY) 2021-12-30 WO disclosed
WO-2018107415-A1 HYDROXY ISOXAZOLE COMPOUNDS USEFUL AS GPR120 AGONISTS MERCK SHARP & DOHME CORP. (US) 2018-06-21 WO disclosed
CN-104662021-B Novel bicyclic pyridinones 辉瑞大药厂 2016-08-24 CN disclosed
CN-103788098-A Azetidine and cyclobutane derivatives as JAK inhibitors INCYTE CORP 2014-05-14 CN disclosed
CN-102026999-B Azetidine and cyclobutane derivatives as JAK inhibitors INCYTE CORP 2014-03-05 CN disclosed
CN-102498118-A Inhibitors of flaviviridae viruses GILEAD SCIENCES INC 2012-06-13 CN disclosed
CN-102471327-A Inhibitors of flaviviridae viruses GILEAD SCIENCES INC 2012-05-23 CN disclosed
CN-102026999-A Azetidine and cyclobutane derivatives as JAK inhibitors INCYTE CORP 2011-04-20 CN disclosed
EP-2139854-A2 P1-NONEPIMERIZABLE KETOAMIDE INHIBITORS OF HCV NS3 PROTEASE SCHERING CORPORATION (US) 2010-01-06 EP disclosed
WO-2009008913-A2 P1-NONEPIMERIZABLE KETOAMIDE INHIBITORS OF HCV NS3 PROTEASE SCHERING CORPORATION (US) 2009-01-15 WO disclosed